Susquehanna International Group
CYTXZ

Susquehanna International Group’s Cytori Therapeutics Inc Series S Warrant CYTXZ Stock Holding History

Susquehanna International Group’s Portfolio CYTXZ Stock Details CYTXZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-188,698
Closed – – 11276
2019
Q2 		$0 Sell
188,698
-30,900
-14% -$77 ﹤0.01% 11203
2019
Q1 		$0 Buy
219,598
+132,139
+151% +$555 ﹤0.01% 10420
2018
Q4 		$1K Buy
+87,459
New +$411 ﹤0.01% 8817

Susquehanna International Group's CYTXZ Position: Q3 2019 in Review

Susquehanna International Group sold out of Cytori Therapeutics Inc Series S Warrant (CYTXZ) in Q3 2019, closing a stake of 188,698 shares.

Susquehanna International Group first reported a position in CYTXZ in Q4 2018 and held it in 3 quarters. The position peaked at $1K in Q4 2018. 0 funds tracked by Wall St. Rank hold CYTXZ as of Q3 2019.

  • Susquehanna International Group reported no remaining Cytori Therapeutics Inc Series S Warrant position as of Q3 2019 after selling out during the quarter.
  • Susquehanna International Group sold 188,698 Cytori Therapeutics Inc Series S Warrant shares in Q3 2019.
  • Susquehanna International Group first reported a position in Cytori Therapeutics Inc Series S Warrant in Q4 2018 and held it in 3 quarters.
  • Susquehanna International Group's Cytori Therapeutics Inc Series S Warrant position peaked at $1K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Series S Warrant as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.